Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner
Begüm Kocatürk(Hacettepe University), Henri H. Versteeg(Leiden University Medical Center), Wolfram Ruf(Scripps Research Institute), J. Sven D. Mieog(Leiden University Medical Center), Gerrit‐Jan Liefers(Leiden University Medical Center), Esther M. de Kruijf(Leiden University Medical Center), Vladimir Y. Bogdanov(National Institutes of Health), Pieter H. Reitsma(Leiden University Medical Center), Martijn A. van der Ent, Peter J.K. Kuppen(Leiden University Medical Center), Chris Tieken, C.C. Engels(Leiden University Medical Center), Susanne Osanto, Cornelis JH van de Velde(Leiden University), Yascha W. van den Berg
Cited by 65
Related Papers
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
|New England Journal of Medicine|1996|1.1k
Gastric cancer
|The Lancet|2009|890
Micrometastases and Survival in Stage II Colorectal Cancer
|New England Journal of Medicine|1998|601
Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.
|Journal of Clinical Oncology|1993|552